Lab
My Clinical Lab INC
My Clinical Lab INC was paid $912K by Medicaid between Apr 2020 and Dec 2024, across 101 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 47% of everything it billed.
33Billing provider infoMY CLINICAL LAB INC
SUNRISE, FL 33326
SUNRISE, FL 33326
33aNPI1386205474assigned 06/28/2019
33bProvider typeClinical Medical Laboratory
28Total paid$912K
24GClaims375,863
24DCodes billed101
24AFirst – last monthApr 2020 – Dec 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Florida
Rank by total paid#43 of 225
Median peer was paid$74K
This provider vs. median12×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 17,101 | $0.00 | |
| 2021 | 9,553 | $25K | |
| 2022 | 109,263 | $423K | |
| 2023 | 134,104 | $373K | |
| 2024incomplete | 105,842 | $91K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 47% | 13,748 | 6,143 | $425K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 9.8% | 11,212 | 8,313 | $90K |
| 80061 | Lipid panel | 3.7% | 24,725 | 17,779 | $33K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.7% | 2,565 | 1,545 | $33K |
| 80053 | Comprehensive metabolic panel | 3.5% | 28,768 | 19,991 | $32K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 3.4% | 8,754 | 4,239 | $31K |
| 84443 | Thyroid stimulating hormone (TSH) | 3.3% | 21,789 | 15,396 | $30K |
| 87186 | 3.3% | 4,076 | 2,743 | $30K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 3.0% | 38,614 | 25,614 | $27K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 2.7% | 2,550 | 881 | $24K |
| 82607 | 2.5% | 12,584 | 8,469 | $23K | |
| 84153 | 1.8% | 3,959 | 2,981 | $16K |
89 more codes
| 83036 | Hemoglobin; glycosylated (A1C) | 1.7% | 22,377 | $16K |
| 80164 | 1.1% | 3,471 | $10K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 6,629 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 9,444 | $7K |
| 87631 | <1% | 387 | $6K | |
| 86769 | <1% | 1,918 | $5K | |
| 80074 | <1% | 302 | $5K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 521 | $5K |
| 81001 | <1% | 14,245 | $4K | |
| 82746 | <1% | 9,115 | $4K | |
| 84439 | <1% | 4,571 | $4K | |
| 87088 | <1% | 5,721 | $3K | |
| 84436 | <1% | 5,498 | $3K | |
| 83880 | <1% | 795 | $2K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 545 | $2K |
| 82140 | <1% | 1,445 | $2K | |
| 84480 | <1% | 2,030 | $2K | |
| 87581 | <1% | 1,026 | $2K | |
| 86328 | <1% | 325 | $2K | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 34,480 | $1K |
| 82378 | <1% | 297 | $1K | |
| 86701 | <1% | 451 | $1K | |
| 82728 | <1% | 2,436 | $1K | |
| 84479 | <1% | 2,897 | $1K | |
| 80076 | <1% | 1,391 | $936.54 | |
| 84403 | <1% | 301 | $844.94 | |
| 84481 | <1% | 852 | $834.06 | |
| 83540 | <1% | 4,724 | $828.89 | |
| 86803 | <1% | 224 | $812.81 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 288 | $810.36 |
| 83970 | <1% | 236 | $764.28 | |
| 87486 | <1% | 450 | $694.63 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 64 | $667.10 |
| 87640 | <1% | 307 | $645.44 | |
| 86696 | <1% | 62 | $645.07 | |
| 86140 | <1% | 1,811 | $615.99 | |
| 84550 | <1% | 1,737 | $615.51 | |
| 87481 | <1% | 582 | $611.92 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 38 | $610.74 |
| 85610 | <1% | 2,238 | $603.82 | |
| 87500 | <1% | 240 | $600.30 | |
| 86480 | <1% | 47 | $579.07 | |
| 83735 | <1% | 2,368 | $577.06 | |
| 84154 | <1% | 805 | $562.77 | |
| 82043 | <1% | 2,548 | $534.88 | |
| 83090 | <1% | 776 | $504.58 | |
| 86695 | <1% | 62 | $436.01 | |
| 87340 | <1% | 108 | $372.54 | |
| 82570 | <1% | 868 | $343.52 | |
| 85730 | <1% | 536 | $318.65 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 120 | $287.09 |
| 86592 | <1% | 286 | $259.20 | |
| 84144 | <1% | 77 | $243.97 | |
| 84100 | <1% | 1,147 | $186.23 | |
| 82550 | <1% | 474 | $160.35 | |
| 85651 | <1% | 1,200 | $157.05 | |
| 86301 | <1% | 79 | $133.54 | |
| 86038 | <1% | 330 | $123.57 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 34,479 | $117.77 |
| 80156 | <1% | 62 | $112.25 | |
| 82274 | <1% | 78 | $74.62 | |
| 84520 | <1% | 110 | $67.99 | |
| 84146 | <1% | 22 | $66.72 | |
| 83550 | <1% | 220 | $66.70 | |
| 84134 | <1% | 265 | $63.82 | |
| 87070 | <1% | 103 | $56.62 | |
| 82105 | <1% | 221 | $48.85 | |
| 80305 | <1% | 46 | $36.81 | |
| 87077 | <1% | 77 | $35.95 | |
| 80069 | <1% | 35 | $23.40 | |
| 86430 | <1% | 256 | $21.58 | |
| 82670 | <1% | 84 | $19.03 | |
| 82248 | <1% | 132 | $12.15 | |
| 84156 | <1% | 14 | $9.86 | |
| 86800 | <1% | 31 | $9.49 | |
| 85044 | <1% | 390 | $9.47 | |
| 82150 | <1% | 30 | $6.98 | |
| 83690 | <1% | 31 | $3.99 | |
| 82565 | <1% | 16 | $3.29 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 7,000 | $1.53 |
| 86300 | 0% | 45 | $0.00 | |
| 87205 | 0% | 20 | $0.00 | |
| 86304 | 0% | 46 | $0.00 | |
| 85045 | 0% | 20 | $0.00 | |
| 83721 | 0% | 20 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 289 | $0.00 |
| 82977 | 0% | 23 | $0.00 | |
| 84466 | 0% | 22 | $0.00 | |
| 87641 | 0% | 30 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMESA, JUAN (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Bay Area Behavior Consultants | Richmond, CA | $6.95M |
| The Abc Group, L.L.C. | Harrisburg, OR | $693K |
| A Behavioral Health Cooperative, L.L.C. | Harrisburg, OR | $153K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.